71 related articles for article (PubMed ID: 25404478)
1. Downregulation of PRRX1 Confers Cancer Stem Cell-Like Properties and Predicts Poor Prognosis in Hepatocellular Carcinoma.
Hirata H; Sugimachi K; Takahashi Y; Ueda M; Sakimura S; Uchi R; Kurashige J; Takano Y; Nanbara S; Komatsu H; Saito T; Shinden Y; Iguchi T; Eguchi H; Atsumi K; Sakamoto K; Doi T; Hirakawa M; Honda H; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1402-9. PubMed ID: 25404478
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of homeoprotein Six1 in hepatocellular carcinoma.
Ng KT; Man K; Sun CK; Lee TK; Poon RT; Lo CM; Fan ST
Br J Cancer; 2006 Oct; 95(8):1050-5. PubMed ID: 17008870
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma: Intratumoral EpCAM-positive cancer stem cell heterogeneity identifies high-risk tumor subtype.
Krause J; von Felden J; Casar C; Fründt TW; Galaski J; Schmidt C; Jung C; Ittrich H; Weidemann SA; Krech T; Heumann A; Li J; Fischer L; Sauter G; Lohse AW; Wege H; Schulze K
BMC Cancer; 2020 Nov; 20(1):1130. PubMed ID: 33225916
[TBL] [Abstract][Full Text] [Related]
4. PRRX1-TOP2A interaction is a malignancy-promoting factor in human malignant peripheral nerve sheath tumours.
Takihira S; Yamada D; Osone T; Takao T; Sakaguchi M; Hakozaki M; Itano T; Nakata E; Fujiwara T; Kunisada T; Ozaki T; Takarada T
Br J Cancer; 2024 May; 130(9):1493-1504. PubMed ID: 38448751
[TBL] [Abstract][Full Text] [Related]
5. Single-cell and spatial analyses revealed the co-location of cancer stem cells and SPP1+ macrophage in hypoxic region that determines the poor prognosis in hepatocellular carcinoma.
Fan G; Xie T; Li L; Tang L; Han X; Shi Y
NPJ Precis Oncol; 2024 Mar; 8(1):75. PubMed ID: 38521868
[TBL] [Abstract][Full Text] [Related]
6. Paired related homeobox 1 is associated with the invasive properties of glioblastoma cells.
Sugiyama M; Hasegawa H; Ito S; Sugiyama K; Maeda M; Aoki K; Wakabayashi T; Hamaguchi M; Natsume A; Senga T
Oncol Rep; 2015 Mar; 33(3):1123-30. PubMed ID: 25522823
[TBL] [Abstract][Full Text] [Related]
7. PRRX1 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer.
Guo J; Fu Z; Wei J; Lu W; Feng J; Zhang S
Med Oncol; 2015 Jan; 32(1):393. PubMed ID: 25428393
[TBL] [Abstract][Full Text] [Related]
8. Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization.
Takano S; Reichert M; Bakir B; Das KK; Nishida T; Miyazaki M; Heeg S; Collins MA; Marchand B; Hicks PD; Maitra A; Rustgi AK
Genes Dev; 2016 Jan; 30(2):233-47. PubMed ID: 26773005
[TBL] [Abstract][Full Text] [Related]
9. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
[TBL] [Abstract][Full Text] [Related]
10. The association of renin-angiotensin system genes with the progression of hepatocellular carcinoma.
Ye G; Qin Y; Lu X; Xu X; Xu S; Wu C; Wang X; Wang S; Pan D
Biochem Biophys Res Commun; 2015 Mar; 459(1):18-23. PubMed ID: 25701390
[TBL] [Abstract][Full Text] [Related]
11. Tumorspheres Derived from HCC Cells are Enriched with Cancer Stem Cell-like Cells and Present High Chemoresistance Dependent on the Akt Pathway.
Zhang XL; Jia Q; Lv L; Deng T; Gao J
Anticancer Agents Med Chem; 2015; 15(6):755-63. PubMed ID: 25642979
[TBL] [Abstract][Full Text] [Related]
12. PRRX1 promotes malignant properties in human osteosarcoma.
Joko R; Yamada D; Nakamura M; Yoshida A; Takihira S; Takao T; Lu M; Sato K; Ito T; Kunisada T; Nakata E; Ozaki T; Takarada T
Transl Oncol; 2021 Jan; 14(1):100960. PubMed ID: 33395745
[TBL] [Abstract][Full Text] [Related]
13. PRRX1 Regulates Cellular Phenotype Plasticity and Dormancy of Head and Neck Squamous Cell Carcinoma Through miR-642b-3p.
Jiang J; Zheng M; Zhang M; Yang X; Li L; Wang SS; Wu JS; Yu XH; Wu JB; Pang X; Tang YJ; Tang YL; Liang XH
Neoplasia; 2019 Feb; 21(2):216-229. PubMed ID: 30622052
[TBL] [Abstract][Full Text] [Related]
14. Paired‑related homeobox 1 overexpression promotes multidrug resistance via PTEN/PI3K/AKT signaling in MCF‑7 breast cancer cells.
Luo H; Cong S; Dong J; Jin L; Jiang D; Wang X; Chen Q; Li F
Mol Med Rep; 2020 Oct; 22(4):3183-3190. PubMed ID: 32945446
[TBL] [Abstract][Full Text] [Related]
15. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X
Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907
[TBL] [Abstract][Full Text] [Related]
16. PRRX1-induced epithelial-to-mesenchymal transition in salivary adenoid cystic carcinoma activates the metabolic reprogramming of free fatty acids to promote invasion and metastasis.
Jiang YP; Tang YL; Wang SS; Wu JS; Zhang M; Pang X; Wu JB; Chen Y; Tang YJ; Liang XH
Cell Prolif; 2020 Jan; 53(1):e12705. PubMed ID: 31657086
[TBL] [Abstract][Full Text] [Related]
17. PRRX1 isoforms cooperate with FOXM1 to regulate the DNA damage response in pancreatic cancer cells.
Marchand B; Pitarresi JR; Reichert M; Suzuki K; Laczkó D; Rustgi AK
Oncogene; 2019 May; 38(22):4325-4339. PubMed ID: 30705403
[TBL] [Abstract][Full Text] [Related]
18. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K
Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151
[TBL] [Abstract][Full Text] [Related]
19. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of PRRX1 via the p53-dependent signaling pathway predicts poor prognosis in hepatocellular carcinoma.
Fan M; Shen J; Liu H; Wen Z; Yang J; Yang P; Liu K; Chang Y; Duan J; Lu K
Oncol Rep; 2017 Aug; 38(2):1083-1090. PubMed ID: 28677793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]